Palliatif treatment with high dose of in 111-pentetreotide In patients with metastatic gastro-entero-pancreatic (GEP) neuroendocrine tumors.

被引：0
|
作者：
Haidar, M
Nguyen, C
De Labriolle-Vaylet, C
Lebtahi, R
Dumont, A
Castilla, A
Genin, R
Le Guludec, D
Askienasy, S
机构：
[1] St Antonius Hosp, Paris, France
[2] Bichat Hosp, Paris, France
来源：
JOURNAL OF NUCLEAR MEDICINE | 2001年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1299
引用
收藏
页码：313P / 313P
页数：1
相关论文
共 50 条
  • [41] CHARACTERISTICS OF LONG-ACTING SOMATOSTATIN (SSA) USE IN GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE (GEP-NET) TUMORS IN THE NETHERLANDS
    Bezemer, I. D.
    Penning, F. J. A.
    Brulais, S.
    Verduyn, C. S. C.
    Herings, R. M. C.
    VALUE IN HEALTH, 2012, 15 (07) : A435 - A435
  • [42] Prognostic Influence of Inflammation-based Risk Scores in Neuroendocrine Tumors of the Gastro-entero-Pancreatic System (GEP-NET)
    Witte, H.
    Ziehm, M.
    Gebauer, J.
    Luley, K.
    Von Bubnoff, N.
    Steinestel, K.
    Bauer, A.
    Gebauer, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 154 - 154
  • [43] Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours
    Angeletti, S
    Corleto, VD
    Schillaci, O
    Moretti, A
    Panzuto, F
    Annibale, B
    Delle Fave, G
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (01): : 23 - 27
  • [44] Feasibility of sornatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours
    Savelli, G
    Lucigani, G
    Seregni, E
    Marchianò, A
    Serafini, G
    Aliberti, G
    Villano, C
    Maccauro, M
    Bombardieri, E
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (05) : 445 - 449
  • [45] CHROMOGRANIN A AS A MARKER IN THE FOLLOWUP OF GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NENS). A SYSTEMATIC REVIEW
    Rossi, R. E.
    Ciafardini, C.
    Conte, D.
    Sciola, V.
    Massironi, S.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E162 - E162
  • [46] Clinical value of In-111-pentetreotide imaging in neuro-endocrine gastro-entero-pancreatic tumors staging and follow-up
    Chiti, A
    Bellanova, B
    Fanti, S
    Romeo, A
    Zoboli, S
    Tomassetti, P
    Savelli, G
    Bombardieri, E
    Monetti, N
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 1121 - 1121
  • [47] ANTIPROLIFERATIVE ACTIVITY OF HIGH DOSE SOMATOSTATIN ANALOGS IN GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE TUMORS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Magi, L.
    Ricci, C.
    Rinzivillo, M.
    Lamberti, G.
    Casadei, R.
    Campana, D.
    Panzuto, F.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S134 - S134
  • [48] Current Status of Interventional Radiology in the Management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs)
    Orgera, Gianluigi
    Krokidis, Miltiadis
    Cappucci, Matteo
    Gourtsoyianni, Sofia
    Tipaldi, Marcello Andrea
    Hatzidakis, Adam
    Rebonato, Alberto
    Rossi, Michele
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2015, 38 (01) : 13 - 24
  • [49] Current Status of Interventional Radiology in the Management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs)
    Gianluigi Orgera
    Miltiadis Krokidis
    Matteo Cappucci
    Sofia Gourtsoyianni
    Marcello Andrea Tipaldi
    Adam Hatzidakis
    Alberto Rebonato
    Michele Rossi
    CardioVascular and Interventional Radiology, 2015, 38 : 13 - 24
  • [50] Impact of Early Surgery on Prognosis in Advanced Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NET)
    Hammer, P.
    Lipp, R.
    Thalhammer, M.
    Mischinger, H. J.
    Kornprat, P.
    Puntschart, A.
    Uranues, S.
    Haybaeck, J.
    Krejs, G.
    Kump, P.
    NEUROENDOCRINOLOGY, 2016, 103 : 98 - 98
12345